BDFS Capital’s Clorox CLX Stock Holding History

BDFS Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,501	Closed	-$570K	–	120
2026 Q1	$570K	Buy	5,501 +808	+17%	+$91.6K	0.27%	69
2025 Q4	$473K	Buy	+4,693	New	+$509K	0.24%	79

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BDFS Capital's CLX Position: Q2 2026 in Review

BDFS Capital sold out of Clorox (CLX) in Q2 2026, closing a stake of 5,501 shares — an estimated $570K sold.

BDFS Capital first reported a position in CLX in Q4 2025 and held it in 2 quarters. The position peaked at $570K in Q1 2026. 1,036 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

BDFS Capital reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
BDFS Capital sold 5,501 Clorox shares in Q2 2026, an estimated $570K.
BDFS Capital first reported a position in Clorox in Q4 2025 and held it in 2 quarters.
BDFS Capital's Clorox position peaked at $570K in Q1 2026.
1,036 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on BDFS Capital's 13F filing for Q2 2026, filed 15 Jul 2026.